| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.093 | 0.09 |